Cigarette smoke increases cardiomyocyte ceramide accumulation and inhibits mitochondrial respiration

BMC Cardiovascular Disorders

Volumn 14, Issue 1, 2014, Pages

  Tippetts, Trevor S ^a   Winden, Duane R ^a   Swensen, Adam C ^b   Nelson, Michael B ^a   Thatcher, Mikayla O ^a   Saito, Rex R ^a   Condie, Tyler B ^a   Simmons, Kurtis J ^a   Judd, Allan M ^a   Reynolds, Paul R ^a   Bikman, Benjamin T ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b N243 Eyring Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CIGARETTE SMOKE; THERMOZYMOCIDIN; CULTURE MEDIUM; MONOUNSATURATED FATTY ACID; SMOKE;

A549 CELL LINE; ADULT; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CARDIAC MUSCLE CELL; CELL DISRUPTION; CELL PERMEABILIZATION; CONTROLLED STUDY; EXPOSURE; HEART MITOCHONDRION; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; LIPID ANALYSIS; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL RESPIRATION; CULTURE MEDIUM; DRUG EFFECTS; HEART MUSCLE CELL; LUNG; METABOLISM; SMOKE; SMOKING; TUMOR CELL LINE; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL RESPIRATION; CERAMIDES; CULTURE MEDIA, CONDITIONED; FATTY ACIDS, MONOUNSATURATED; HUMANS; INHALATION EXPOSURE; LUNG; MALE; MICE, INBRED C57BL; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; SMOKE; SMOKING; UP-REGULATION;

EID: 84929941122     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-165     Document Type: Article

References (37)

1. WHO urges more countries to require large, graphic health warnings on tobacco packaging: the WHO report on the global tobacco epidemic, 2011 examines anti-tobacco mass-media campaigns. Cent Eur J Public Health 2011, 19:133-151.
2. Deitel M: Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg 2003, 13:329-330.
3. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD, Murray CJL, Gakidou E: Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014, 311:183-192.
4. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration 2011.
5. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR: Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 1996, 275:1233-1240.
6. Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF: Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect 2006, 114:853-858.
7. Vital signs: nonsmokers' exposure to secondhand smoke-United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2010, 59:1141-1146.
8. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008, 57:1226-1228.
9. Lakier JB: Smoking and cardiovascular disease. Am J Med 1992, 93:8S-12S.
10. Lopaschuk GD, Jaswal JS: Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol 2010, 56:130-140.
11. Winter SC, Buist NR: Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine. Am Heart J 2000, 139:S63-69.
12. Holmgren D, Wahlander H, Eriksson BO, Oldfors A, Holme E, Tulinius M: Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J 2003, 24:280-288.
13. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL: Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 2001, 33:1065-1089.
14. Miro O, Alonso JR, Jarreta D, Casademont J, Urbano-Marquez A, Cardellach F: Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 1999, 20:1331-1336.
15. Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, Pinkerton KE, Ischiropoulos H, Ballinger SW: Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002, 105:849-854.
16. Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, Nawroth PP, Paine R 3rd, Hoidal JR: Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mol Biol 2010, 42:545-551.
17. Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, Pagliassotti MJ, Scherer PE, Summers SA: Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011, 121:1858-1870.
18. Bikman BT: A role for sphingolipids in the pathophysiology of o besity-induced inflammation. CMLS 2012, 69:2135-2146.
19. Bikman BT, Summers SA: Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 2011, 121:4222-4230.
20. Gudz TI, Tserng KY, Hoppel CL: Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J Biol Chem 1997, 272:24154-24158.
21. Marin-Garcia J, Goldenthal MJ, Pierpont ME, Ananthakrishnan R: Impaired mitochondrial function in idiopathic dilated cardiomyopathy: biochemical and molecular analysis. J Card Fail 1995, 1:285-291.
22. Reynolds PR, Cosio MG, Hoidal JR: Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol Biol 2006, 35:314-319.
23. Fahy E, Subramaniam S, Murphy RC, Nishijima M, Raetz CR, Shimizu T, Spener F, van Meer G, Wakelam MJ, Dennis EA: Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 2009, 50(Suppl):S9-14.
24. Smith ME, Tippetts TS, Brassfield ES, Tucker BJ, Ockey A, Swensen AC, Anthonymuthu TS, Washburn TD, Kane DA, Prince JT, Bikman BT: Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle. Biochem J 2013, 456:427-439.
25. Wilson CR, Tran MK, Salazar KL, Young ME, Taegtmeyer H: Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem J 2007, 406:457-467.
26. Baranowski M, Blachnio A, Zabielski P, Gorski J: PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet. J Physiol Pharmacol 2007, 58:57-72.
27. Gvozdjakova A, Bada V, Sany L, Kucharska J, Kruty F, Bozek P, Trstansky L, Gvozdjak J: Smoke cardiomyopathy: disturbance of oxidative processes in myocardial mitochondria. Cardiovasc Res 1984, 18:229-232.
28. Lough J: Cardiomyopathy produced by cigarette smoke. Ultrastructural observations in guinea pigs. Arch Pathol Lab Med 1978, 102:377-380.
29. Thatcher MO, Tippetts TS, Nelson MB, Swensen AC, Winden DR, Hansen ME, Anderson MC, Johnson IE, Porter JP, Prince JT, Reynolds PR, Bikman BT: Ceramides mediate cigarette smoke-induced metabolic disruption in mice. Am J Physiol Endocrinol Metab 2014.
30. Cullen P, Schulte H, Assmann G: Smoking, lipoproteins and coronary heart disease risk. Data from the Munster Heart Study (PROCAM). Eur Heart J 1998, 19:1632-1641.
31. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, Webb DJ: Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 1999, 99:1411-1415.
32. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM: Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005, 11:491-498.
33. Novgorodov SA, Gudz TI: Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol 2009, 53:198-208.
34. Schweitzer KS, Hatoum H, Brown MB, Gupta M, Justice MJ, Beteck B, Van Demark M, Gu Y, Presson RG Jr, Hubbard WC, Petrache I: Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides. Am J Physiol Lung Cell Mol Physiol 2011, 301:L836-846.
35. Filosto S, Castillo S, Danielson A, Franzi L, Khan E, Kenyon N, Last J, Pinkerton K, Tuder R, Goldkorn T: Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury. Am J Respir Cell Mol Biol 2011, 44:350-360.
36. Levy M, Khan E, Careaga M, Goldkorn T: Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am J Physiol Lung Cell Mol Physiol 2009, 297:L125-133.
37. Bikman BT, Guan Y, Shui G, Siddique MM, Holland WL, Kim JY, Fabrias G, Wenk MR, Summers SA: Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis. J Biol Chem 2012, 287:17426-17437.